跳至主要内容
临床试验/JPRN-jRCT2080220414
JPRN-jRCT2080220414未知2 期

Dose-ranging trial of OPC-249 powder inhalation in patients with pain due to osteoporosis

Otsuka Pharmaceutical Co., Ltd.0 个研究点开始时间: 2007年7月13日最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 46age old 至 <= 79age old(—)
性别
Female

入选标准

  • Patients who fulfill all of the following items
  • -Patients with primary osteoporosis
  • -Patients who have existing 1-4 vertebral fractures
  • -Patients with back pain persisting for one week or more
  • -Postmenopausal women between 46 and less than 80 years of age

排除标准

  • 未提供

研究者

相似试验

已完成
2 期
Dose-ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to OsteoporosisPain Due to Osteoporosis
NCT00504426Otsuka Pharmaceutical Co., Ltd.101
进行中(未招募)
1 期
Trial to test the safety, half-life, and antiviral efficacy of a new drug (human antibody) called DZIF-10c (administered inhalatively) in healthy volunteers and SARS-CoV-2-infected participantsSARS-CoV-2 infection (only mild to moderate disease)MedDRA version: 23.0Level: LLTClassification code 10084272Term: SARS-CoV-2 infectionSystem Organ Class: 100000004862
EUCTR2020-004448-27-DEniversity of Cologne96
尚未招募
不适用
A RANDOMIZED DOUBLE BLIND ACTIVE CONTROLLED PARALLEL TRIAL TO COMPARE THE EFFECT OF INHALATION OF COOLER AIR(OF DIFFERENT TEMPERATURES 18-22&deg;c,23-27&deg;c AND 28-30&deg;c)WITH WARMER AIR(33-37&deg;c)ON SYMPTOMS AND LUNG FUNCTIONS IN PATIENTS WITH BRONCHIAL ASTHMA OF MILD SEVERITY
CTRI/2009/091/000701MITTAL HOSPITA150
尚未招募
2 期
A Phase 2 clinical trial of Inhaled Unfractionated Heparin (UFH) for the tretatment of Hospitalised Patients with COVID-19Coronavirus infection in unspecified location
RBR-8r9hy8fGaleno Desenvolvimento de Pesquisas Clínicas Ltda
已完成
2 期
Effect of inhaled pharmaceutical Penthrox (Methoxyflurane) on pain of limb fractureCondition 1: Sequelae of fracture of arm. Condition 2: Sequelae of other fractures of lower limb.Sequelae of injury classifiable to S42.-, S52.- and T10Sequelae of injury classifiable to S82.-, S92.- and T12
IRCT2015111724799N3Vice chancellor for research, Baqiyatallah University of Medical Sciences100